The Covid-19 pandemic has disrupted the country's TB programme, and led to a decline in the diagnosis rate. Now it seems that the health system is seeing an increase in patients presenting with more advanced TB...
Mohammed Rassool & Pauline Howell 24 Mar 2021
There is a clamour by some people for ivermectin to be approved by the South African Health Products Regulatory Authority (Sahpra) to treat Covid-19...
Rufaro Samanga 15 Jan 2021
It is crucial to monitor patients taking the new drug for multidrug-resistant tuberculosis (MDR-TB), bedaquiline, to prevent resistance...
Elsabé Brits 11 Jul 2019
Scientists from Stellenbosch University (SU), in collaboration with a multidisciplinary team of researchers and clinicians, are working on how Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB), can develop resistance to Bedaquiline...
A new programme in the fight against drug-resistant tuberculosis (DR-TB) that is expected to slash treatment times and minimise side-effects has been launched...
The suffering and massive loss of life caused by tuberculosis (TB) are proof that humanity hasn't prioritised the development of tools to eliminate a disease dating back 9,000 years.
Bavesh Kana 22 Mar 2019
The Democratic Republic of the Congo (DRC) is home to an estimated 81-million people and a high-burden country for tuberculosis (TB), TB/HIV and multi-drug resistant TB (MDR-TB).
Patients with multidrug-resistant tuberculosis (MDR-TB) will now be able to receive life changing treatment as the Department of Health begins its roll-out of Bedaquiline...
The informal settlement of Khayelitsha in Cape Town is the latest site of a multi country trial that aims to transform the treatment for drug-resistant tuberculosis (DR-TB).
Eric Goemaere 31 May 2018
While the incidence of drug-susceptible (DS-TB), which is treated with the antibiotics rifampicin and isoniazid, has marginally declined in the past decade, there has been a marked increase in drug-resistant TB (DR-TB).
A deal brokered with the health department guarantees free access to a new TB drug, but for how long?
JOAN VAN DYK 15 Mar 2017
A new research unit geared towards making TB drugs safe and accessible for children recently opened its doors at the Brooklyn Chest Hospital...
![[#WomenInBiz] Physician heal thyself, Q&A with Dr Dalene von Delft](https://biz-file.com/c/1508/302048-120x120.jpg)
When Dalene von Delft started working as a doctor, she knew there were risks. But what she didn't bargain for was contracting a life-threatening disease...
Nicci Botha 14 Aug 2015
South Africa is one of three countries (together with India and Ukraine) with the largest increase in multidrug-resistant TB (MDR-TB), and with a treatment success rate of only 48% (according to a 2014 World Health Global TB report)...
Approximately 3,000 South African patients who suffer from multidrug-resistant tuberculosis (MDR-TB) will now be able to receive SIRTURO (bedaquiline) in the next year, following approval by South Africa's Medicines Control Council (MCC).